Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghao Zhou

Showing results (161-170 of 197) with videos related to

Pageof 20
Sort By:
Frontiers in Pharmacology|January 9, 2019
Intensive Glucose Control Reduces the Risk Effect of <i>TRIB3, SMARCD3</i>, and <i>ATF6</i> Genetic Variation on Diabetic Vascular ComplicationsFazhong He, Yan Shu, Xingyu Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 12, 2015
Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicityJuan Chen, Lin Wu, Ying Wang, et al.
International Journal of Cancer|August 10, 2017
The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapyYi Zheng, Zheng Deng, Jiye Yin, et al.
Nutrients|January 21, 2023
<i>Bifidobacterium pseudocatenulatum</i>-Mediated Bile Acid Metabolism to Prevent Rheumatoid Arthritis via the Gut-Joint AxisQing Zhao, Huan Ren, Nian Yang, et al.
Plos One|April 25, 2013
The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in ChinaFazhong He, Jianquan Luo, Zhiying Luo, et al.
International Journal of Molecular Sciences|November 19, 2014
WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patientsJuan Chen, Jiye Yin, Xiangping Li, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2016
Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patientsTing Zou, Jiye Yin, Wei Zheng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its applicationRong Fan, Xi Huang, Yang Wang, et al.
Plos One|April 8, 2015
The RGS2 (-391, C>G) genetic variation correlates to antihypertensive drug responses in Chinese patients with essential hypertensionFazhong He, Jianquan Luo, Zhitao Zhang, et al.
Ebiomedicine|October 30, 2016
Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering TreatmentFazhong He, Mouze Liu, Zhangren Chen, et al.
Pageof 20

Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Frontiers in Pharmacology|January 9, 2019
Intensive Glucose Control Reduces the Risk Effect of <i>TRIB3, SMARCD3</i>, and <i>ATF6</i> Genetic Variation on Diabetic Vascular ComplicationsFazhong He, Yan Shu, Xingyu Wang, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 12, 2015
Effect of transporter and DNA repair gene polymorphisms to lung cancer chemotherapy toxicityJuan Chen, Lin Wu, Ying Wang, et al.
International Journal of Cancer|August 10, 2017
The association of genetic variations in DNA repair pathways with severe toxicities in NSCLC patients undergoing platinum-based chemotherapyYi Zheng, Zheng Deng, Jiye Yin, et al.
Nutrients|January 21, 2023
<i>Bifidobacterium pseudocatenulatum</i>-Mediated Bile Acid Metabolism to Prevent Rheumatoid Arthritis via the Gut-Joint AxisQing Zhao, Huan Ren, Nian Yang, et al.
Plos One|April 25, 2013
The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in ChinaFazhong He, Jianquan Luo, Zhiying Luo, et al.
International Journal of Molecular Sciences|November 19, 2014
WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patientsJuan Chen, Jiye Yin, Xiangping Li, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2016
Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patientsTing Zou, Jiye Yin, Wei Zheng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 29, 2012
Ethnopharmacokinetic- and activity-guided isolation of a new antidepressive compound from fructus aurantii found in the traditional chinese medicine chaihu-shugan-san: a new approach and its applicationRong Fan, Xi Huang, Yang Wang, et al.
Plos One|April 8, 2015
The RGS2 (-391, C>G) genetic variation correlates to antihypertensive drug responses in Chinese patients with essential hypertensionFazhong He, Jianquan Luo, Zhitao Zhang, et al.
Ebiomedicine|October 30, 2016
Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering TreatmentFazhong He, Mouze Liu, Zhangren Chen, et al.
Pageof 20